Page 1161 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 64 Pathobiology of Acute Lymphoblastic Leukemia 1019.e1

REFERENCES 23. Pui CH, Behm FG, Crist WM: Clinical and biologic relevance of
immunologic marker studies in childhood acute lymphoblastic leuke-
1. Market E, Papavasiliou FN: V(D)J recombination and the evolution of mia. Blood 82(2):343–362, 1993.
the adaptive immune system. PLoS Biol 1(1):E16, 2003. 24. Korsmeyer SJ, Arnold A, Bakhshi A, et al: Immunoglobulin gene
2. Swaminathan S, Klemm L, Park E, et al: Mechanisms of clonal rearrangement and cell surface antigen expression in acute lympho-
evolution in childhood acute lymphoblastic leukemia. Nat Immunol cytic leukemias of T cell and B cell precursor origins. J Clin Invest
16(7):766–774, 2015. 71(2):301–313, 1983.
3. Papaemmanuil E, Rapado I, Li Y, et al: RAG-mediated recombination is 25. Korsmeyer SJ, Hieter PA, Ravetch JV, et al: Developmental hierarchy of
the predominant driver of oncogenic rearrangement in ETV6-RUNX1 immunoglobulin gene rearrangements in human leukemic pre-B-cells.
acute lymphoblastic leukemia. Nat Genet 46(2):116–125, 2014. Proc Natl Acad Sci USA 78(11):7096–7100, 1981.
4. Kohlmann A, Schoch C, Schnittger S, et al: Pediatric acute lymphoblas- 26. Kitchingman GR, Rovigatti U, Mauer AM, et al: Rearrangement of
tic leukemia (ALL) gene expression signatures classify an independent immunoglobulin heavy chain genes in T cell acute lymphoblastic
cohort of adult ALL patients. Leukemia 18(1):63–71, 2004. leukemia. Blood 65(3):725–729, 1985.
5. Armstrong SA, Look AT: Molecular genetics of acute lymphoblastic 27. Hatano M, Roberts CW, Minden M, et al: Deregulation of a
leukemia. J Clin Oncol 23(26):6306–6315, 2005. homeobox gene, HOX11, by the t(10;14) in T cell leukemia. Science
6. Nowell PC, Hungerford DA: Chromosome studies in human leukemia. 253(5015):79–82, 1991.
II. Chronic granulocytic leukemia. J Natl Cancer Inst 27:1013–1035, 28. Ford AM, Molgaard HV, Greaves MF, et al: Immunoglobulin gene
1961. organisation and expression in haemopoietic stem cell leukaemia.
7. Arnold A, Cossman J, Bakhshi A, et al: Immunoglobulin-gene rear- EMBO J 2(6):997–1001, 1983.
rangements as unique clonal markers in human lymphoid neoplasms. 29. Reinherz EL, Schlossman SF: Current concepts in immunology: Regu-
N Engl J Med 309(26):1593–1599, 1983. lation of the immune response–inducer and suppressor T-lymphocyte
8. Waldmann TA, Davis MM, Bongiovanni KF, et al: Rearrangements of subsets in human beings. N Engl J Med 303(7):370–373, 1980.
genes for the antigen receptor on T cells as markers of lineage and clon- 30. Rothenberg EV, Taghon T: Molecular genetics of T cell development.
ality in human lymphoid neoplasms. N Engl J Med 313(13):776–783, Annu Rev Immunol 23:601–649, 2005.
1985. 31. Reinherz EL, Nadler LM, Sallan SE, et al: Subset derivation of T-cell
9. Dow LW, Martin P, Moohr J, et al: Evidence for clonal development acute lymphoblastic leukemia in man. J Clin Invest 64(2):392–397,
of childhood acute lymphoblastic leukemia. Blood 66(4):902–907, 1979.
1985. 32. Nadler LM, Reinherz EL, Weinstein HJ, et al: Heterogeneity of T-cell
10. Pui CH, Raskind WH, Kitchingman GR, et al: Clonal analysis of child- lymphoblastic malignancies. Blood 55(5):806–810, 1980.
hood acute lymphoblastic leukemia with “cytogenetically independent” 33. Bernard A, Boumsell L, Reinherz EL, et al: Cell surface characterization
cell populations. J Clin Invest 83(6):1971–1977, 1989. of malignant T cells from lymphoblastic lymphoma using monoclonal
11. Kersey J, Nesbit M, Hallgren H, et al: Evidence for origin of certain antibodies: evidence for phenotypic differences between malignant T
childhood acute lymphoblastic leukemias and lymphomas in thymus- cells from patients with acute lymphoblastic leukemia and lymphoblas-
derived lymphocytes. Cancer 36(4):1348–1352, 1975. tic lymphoma. Blood 57(6):1105–1110, 1981.
12. Sen L, Borella L: Clinical importance of lymphoblasts with T markers 34. Roper M, Crist WM, Metzgar R, et al: Monoclonal antibody character-
in childhood acute leukemia. N Engl J Med 292(16):828–832, 1975. ization of surface antigens in childhood T-cell lymphoid malignancies.
13. Greaves MF: Differentiation-linked leukemogenesis in lymphocytes. Blood 61(5):830–837, 1983.
Science 234(4777):697–704, 1986. 35. Czuczman MS, Dodge RK, Stewart CC, et al: Value of immunopheno-
14. Bennett JM, Catovsky D, Daniel MT, et al: The morphological classifi- type in intensively treated adult acute lymphoblastic leukemia: cancer
cation of acute lymphoblastic leukaemia: concordance among observers and leukemia Group B study 8364. Blood 93(11):3931–3939, 1999.
and clinical correlations. Br J Haematol 47(4):553–561, 1981. 36. Goldberg JM, Silverman LB, Levy DE, et al: Childhood T-cell
15. Pui CH, Crist WM, Look AT: Biology and clinical significance of acute lymphoblastic leukemia: the Dana-Farber Cancer Institute
cytogenetic abnormalities in childhood acute lymphoblastic leukemia. acute lymphoblastic leukemia consortium experience. J Clin Oncol
Blood 76(8):1449–1463, 1990. 21(19):3616–3622, 2003.
16. Pui CH: Childhood leukemias. N Engl J Med 332(24):1618–1630, 37. Pullen J, Shuster JJ, Link M, et al: Significance of commonly used
1995. prognostic factors differs for children with T cell acute lymphocytic leu-
17. Murphy SB, Bowman WP, Abromowitch M, et al: Results of treat- kemia (ALL), as compared to those with B-precursor ALL. A Pediatric
ment of advanced-stage Burkitt’s lymphoma and B cell (SIg+) acute Oncology Group (POG) study. Leukemia 13(11):1696–1707, 1999.
lymphoblastic leukemia with high-dose fractionated cyclophosphamide 38. Coustan-Smith E, Mullighan CG, Onciu M, et al: Early T-cell precursor
and coordinated high-dose methotrexate and cytarabine. J Clin Oncol leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia.
4(12):1732–1739, 1986. Lancet Oncol 10(2):147–156, 2009.
18. Patte C, Philip T, Rodary C, et al: High survival rate in advanced-stage 39. Gutierrez A, Dahlberg SE, Neuberg DS, et al: Absence of biallelic
B-cell lymphomas and leukemias without CNS involvement with a TCRgamma deletion predicts early treatment failure in pediatric
short intensive polychemotherapy: results from the French Pediatric T-cell acute lymphoblastic leukemia. J Clin Oncol 28(24):3816–3823,
Oncology Society of a randomized trial of 216 children. J Clin Oncol 2010.
9(1):123–132, 1991. 40. Zhang J, Ding L, Holmfeldt L, et al: The genetic basis of early T-cell
19. Schwenn MR, Blattner SR, Lynch E, et al: HiC-COM: a 2-month precursor acute lymphoblastic leukaemia. Nature 481(7380):157–163,
intensive chemotherapy regimen for children with stage III and IV 2012.
Burkitt’s lymphoma and B-cell acute lymphoblastic leukemia. J Clin 41. Van Vlierberghe P, Ambesi-Impiombato A, Perez-Garcia A, et al:
Oncol 9(1):133–138, 1991. ETV6 mutations in early immature human T cell leukemias. J Exp
20. Reiter A, Schrappe M, Ludwig WD, et al: Favorable outcome of B-cell Med 208(13):2571–2579, 2011.
acute lymphoblastic leukemia in childhood: a report of three consecu- 42. Smith LJ, Curtis JE, Messner HA, et al: Lineage infidelity in acute
tive studies of the BFM group. Blood 80(10):2471–2478, 1992. leukemia. Blood 61(6):1138–1145, 1983.
21. Cairo MS, Sposto R, Perkins SL, et al: Burkitt’s and Burkitt-like lym- 43. Mirro J, Zipf TF, Pui CH, et al: Acute mixed lineage leukemia:
phoma in children and adolescents: a review of the Children’s Cancer clinicopathologic correlations and prognostic significance. Blood
Group experience. Br J Haematol 120(4):660–670, 2003. 66(5):1115–1123, 1985.
22. Thomas DA, Faderl S, O’Brien S, et al: Chemoimmunotherapy with 44. Greaves MF, Chan LC, Furley AJ, et al: Lineage promiscuity in hemo-
hyper-CVAD plus rituximab for the treatment of adult Burkitt and poietic differentiation and leukemia. Blood 67(1):1–11, 1986.
Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer 45. Pui CH, Rubnitz JE, Hancock ML, et al: Reappraisal of the clinical
106(7):1569–1580, 2006. and biologic significance of myeloid-associated antigen expression in